Health
Glucosidase inhibitors are promising as new therapeutic agents for SARS-CoV-2 – Eminetra
In a new study posted on bioRxiv* Preprint server, US researchers found that two iminosugar glucosidase inhibitors suppress the replication of severe acute respiratory…
In a new study posted on bioRxiv* Preprint server, US researchers found that two iminosugar glucosidase inhibitors suppress the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in tissue culture at least one-hundredth of the required concentration. It reports that it has the ability to do so because of its cytotoxic effects.
As the pandemic of coronavirus disease 2019 (COVID-19) progresses, there is an urgent need for new antiviral agents that are effective against SARS-CoV-2,…
-
General23 hours agoMatildas vs Panama international friendly — live blog and scores from Bunbury
-
Noosa News23 hours agoPolice appeal for information after two men found dead
-
General23 hours agoTariff letters to 12 countries going out Monday: Trump
-
General23 hours agoCan the world be governed without the US? • Inside Story